Enhertu 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FCYX8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,384
Award facts
- Contract value 100% obligated
- $23,383.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $23,383.56 to DMS Pharmaceutical Group Inc. for 100 mg vials of Enhertu, an oncology pharmaceutical product. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded this firm fixed-price delivery order on November 25, 2025, with an ultimate completion date of November 26, 2025. The contract utilizes no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The place of performance is located in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. That underlying IDC, valued at $499,999,999 and awarded on November 13, 2025, authorizes the Defense Logistics Agency to issue delivery orders for a comprehensive range of pharmaceutical products, branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the Department of Defense's military healthcare facilities worldwide. The PPV-G GEN V represents part of a broader $30.3 billion acquisition strategy, with DMS Pharmaceutical Group positioned as a regional prime vendor contractor alongside other qualified suppliers.
Quick answers
Who was awarded contract SPE2DR26FCYX8?
SPE2DR26FCYX8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26FCYX8 worth?
The government has obligated $23,384 on SPE2DR26FCYX8.
Is contract SPE2DR26FCYX8 an order under another contract?
Yes. SPE2DR26FCYX8 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCYX8 competed?
The extent of competition for SPE2DR26FCYX8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award